Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Metformin in the Treatment of Fragile X Syndrome

NCT05120505 is registered in ClinicalTrials.gov with Children's Hospital of Fudan University as lead sponsor.

NCT NCT05120505
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05120505 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Metformin in the Treatment of Fragile X Syndrome
Lead sponsor
Children's Hospital of Fudan University
Phase
Phase 4
Overall status
Completed
Start date
December 29, 2021
Completion date
January 30, 2025
Enrollment
37 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fragile x syndrome, metformin